Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 18,766	$ 12,126
Accounts receivable	0	173
Promissory note receivable	0	12,243
Prepaid expenses and other current assets	1,846	2,537
Current deposits	15	15
Total current assets	20,627	27,094
Property and equipment, net	185	207
Operating lease right-of-use assets	324	349
Long-term investments	7,692	5,588
Total assets	28,828	33,238
Current liabilities:
Accounts payable and accrued expenses	8,358	7,313
Current portion of operating lease liabilities	157	154
Current portion of contract liabilities	17	17
Current portion of notes payable	0	224
Total current liabilities	8,532	7,708
Contract liabilities, net of current portion	18,669	18,669
Operating lease liabilities, net of current portion	297	338
Warrant liability, related party	922	684
Total liabilities	28,420	27,399
Commitments and contingencies
Redeemable noncontrolling interest	19,600	16,579
Stockholders’ deficit:
Additional paid-in capital	254,080	253,737
Accumulated deficit	(274,319)	(265,524)
Total stockholders’ deficit attributable to vTv Therapeutics Inc.	(19,192)	(10,740)
Total liabilities, redeemable noncontrolling interest and stockholders’ deficit	28,828	33,238
Class A Common Stock
Stockholders’ deficit:
Common stock value	815	815
Class B Common Stock
Stockholders’ deficit:
Common stock value	$ 232	$ 232